Document is current
Any future updates will be listed below
-
Authors
Thomassen, Britt J.M. https://orcid.org/0009-0004-2631-5649
Hendrix, Evelien M.B. https://orcid.org/0000-0003-0482-4640
Mujagic, Zlatan https://orcid.org/0000-0001-5211-0381
Smeets, Fabiënne G.M. https://orcid.org/0000-0002-1761-8312
de Jong, Marin J. https://orcid.org/0000-0002-4197-6638
Gevers, Tom J.G. https://orcid.org/0000-0002-3070-8443
Veldhuijzen, Govert https://orcid.org/0000-0003-2172-9098
van der Horst, Daniëlle
Scherpenzeel, Menne
Dijkstra, Gerard https://orcid.org/0000-0003-4563-7462
Kimman, Merel L. https://orcid.org/0000-0002-5717-5704
Ament, Stephanie M.C. https://orcid.org/0000-0002-6186-1563
Pierik, Marieke J. https://orcid.org/0000-0001-6981-6516
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 29 April 2025
First Online: 10 May 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethical Committee of the Maastricht University Medical Centre+ (MUMC+) [METC 2023–3679]. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: BT, EH, FS, MdJ, GV, DvdH, MK, and SA have no relevant financial or non-financial interests to disclose. ZM reports grants from Niels Stensen Fellowship, MLDS, ZonMw, TKI and Galapagos, advisory board fees from Johnson & Johnson, Lilly, Pfizer (paid to host institution), and received speaker’s fees from Galapagos and Takeda (paid to host institution), all outside the submitted work. TG received grants from Gilead and AbbVie. MS served on the patient advisory board of Janssen and Pfizer and received a speaker’s fee from Abbvie for participating in a webinar, all on behalf of Crohn & Colitis NL and outside the submitted work. GD received grant support from Royal DSM, served as a consultant for Astra-Zenica, and received a speaker’s fee from AbbVie, all outside the submitted work. MP reports grants and non-financial support from Falk Pharma, grants from European Commission, grants from ZonMw (Dutch national research fund), grants and non-financial support from Takeda, grants and non-financial support from Johnson and Johnson, grants and non-financial support from AbbVie, non-financial support from Ferring, non-financial support from Immunodiagnostics, non-financial support from MSD, all outside the submitted work.
